AXCYNSIS THERAPEUTICS
Who is AXCYNSIS THERAPEUTICS?
Axcynsis Therapeutics Pte. Ltd. is a platform-based biotech company dedicated to creating novel antibody-conjugate (AXC) therapies to transform cancer care. By harnessing proprietary technologies, we are building a diverse portfolio of AXC candidates with the potential to address unmet medical needs...See more
Industry & Specialities
Others
Countries of Operation
Singapore
Headquarters:
Singapore
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2022 (4 years)
Address:
41 SCIENCE PARK ROAD; SINGAPORE, 117610, SG
Employees by Department
- Operations (1)
- The Rest (4)
- Total (5)
Key Decision Makers
Yun Xuan Wong
Operations Manager
Alex Ling
Antibody Scientist
Kah Man Lai
Scientist
Zou Bin
Founder and CEO
Insight
Signals
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
1employees
Senior
0employees
Non-managers
2employees
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has AXCYNSIS THERAPEUTICS been operating for?
- What is the funding status of AXCYNSIS THERAPEUTICS?
- Where is AXCYNSIS THERAPEUTICS's headquarter?
- What AXCYNSIS THERAPEUTICS's spending power?
- Does AXCYNSIS THERAPEUTICS have a presence in the domain it operates in?